Selective inhibition of the A form of monoamine oxidase by 4-dimethylamino-alpha-methylphenylalkylamine derivatives in the rat
- PMID: 7088264
- DOI: 10.1016/0028-3908(82)90092-2
Selective inhibition of the A form of monoamine oxidase by 4-dimethylamino-alpha-methylphenylalkylamine derivatives in the rat
Abstract
The inhibitory effects on monoamine oxidase (MAO) of some dimethylamino-alpha-phenylalkylamine derivatives were examined in a rat brain mitochondrial preparation in vitro and in rat brain slices following oral administration. In the in vitro assay the compounds were shown to be selective inhibitors of the A form of MAO, being 100-600 times more potent in inhibiting the deamination of [14C]5-hydroxytryptamine than that of [14C]phenetylamine. Using an ex vivo brain slice technique it was found that the new compounds were reversible and very selective inhibitors of type A MAO in the rat brain and the most potent compounds (FLA 405, 314, 336 and 558) were equipotent with clorgyline. The compounds increased the monoamine concentrations in whole rat brain, particularly that of 5-hydroxytryptamine, in the same dose range which produced MAO inhibition. Some of the new compounds, e.g. FLA 336 and FLA 717, caused only weak potentiation of the vaso-pressor effect of orally administered tyramine.
Similar articles
-
Selective inhibition by amiflamine of monoamine oxidase type A in rat brain, liver and duodenum.Naunyn Schmiedebergs Arch Pharmacol. 1984 Aug;327(1):56-63. doi: 10.1007/BF00504992. Naunyn Schmiedebergs Arch Pharmacol. 1984. PMID: 6493351
-
(+)-4-Dimethylamino-2,alpha-dimethylphenethylamine (FLA 336(+)), a selective inhibitor of the A form of monoamine oxidase in the rat brain.Biochem Pharmacol. 1982 Apr 1;31(7):1401-6. doi: 10.1016/0006-2952(82)90035-1. Biochem Pharmacol. 1982. PMID: 7092929
-
A and B forms of monoamine oxidase within the monoaminergic neurons of the rat brain.J Neurochem. 1986 Aug;47(2):569-76. doi: 10.1111/j.1471-4159.1986.tb04537.x. J Neurochem. 1986. PMID: 3734795
-
On the dual nature of monoamine oxidase.Horiz Biochem Biophys. 1978;5:37-64. Horiz Biochem Biophys. 1978. PMID: 355087 Review. No abstract available.
-
Pharmacology of reversible and selective inhibitors of monoamine oxidase type A.Acta Psychiatr Scand Suppl. 1995;386:8-13. doi: 10.1111/j.1600-0447.1995.tb05918.x. Acta Psychiatr Scand Suppl. 1995. PMID: 7717096 Review.
Cited by
-
Amphetamine Derivatives as Monoamine Oxidase Inhibitors.Front Pharmacol. 2020 Jan 23;10:1590. doi: 10.3389/fphar.2019.01590. eCollection 2019. Front Pharmacol. 2020. PMID: 32038257 Free PMC article. Review.
-
Selective inhibition by amiflamine of monoamine oxidase type A in rat brain, liver and duodenum.Naunyn Schmiedebergs Arch Pharmacol. 1984 Aug;327(1):56-63. doi: 10.1007/BF00504992. Naunyn Schmiedebergs Arch Pharmacol. 1984. PMID: 6493351
-
Inhibition of monoamine oxidase in 5-hydroxytryptaminergic neurones by substituted p-aminophenylalkylamines.Br J Pharmacol. 1985 Jul;85(3):683-90. doi: 10.1111/j.1476-5381.1985.tb10564.x. Br J Pharmacol. 1985. PMID: 3861206 Free PMC article.
-
Release of 3H-5-hydroxytryptamine by amiflamine and related phenylalkylamines from rat occipital cortex slices.Naunyn Schmiedebergs Arch Pharmacol. 1989 Jun;339(6):684-9. doi: 10.1007/BF00168662. Naunyn Schmiedebergs Arch Pharmacol. 1989. PMID: 2770890
-
Effect of repeated amiflamine administration on serotonergic and noradrenergic neurotransmission: electrophysiological studies in the rat CNS.Naunyn Schmiedebergs Arch Pharmacol. 1986 Nov;334(3):253-60. doi: 10.1007/BF00508779. Naunyn Schmiedebergs Arch Pharmacol. 1986. PMID: 3808082